Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

Inclusion criteria

• ✓. Androgenic alopecia
• ✓. Traction alopecia
• ✓. Scarring alopecia
• ✓. Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
• ✓. No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
• ✓. Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
• ✓. Tixel of the face
• ✓. Keralase of the scalp (scalp treatment closed to enrollment)